NCT06596200

Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy

Pilot Study for the Use of Spinal Cord Stimulation to Alleviate Pain from Chemotherapy Induced Peripheral Neuropathy Due to Taxane or Platinum Based Agents

• Status: Not Yet Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: University of Maryland St. Joseph Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Spinal Cord Stimulation using 10 kHz stimulation to the thoracic spinal cord will be a safe and effective treatment for CIPN, reducing pain in the lower extremities by at least 50%.

Conditions

• Chemotherapy-induced Peripheral Neuropathy

Interventions

Type	Name	Description
DEVICE	Spinal Cord Stimulation Implant	Spinal Cord Stimulation using 10 kHz stimulation to the thoracic spinal cord

Timeline

• Start date: 2024-09-15
• Primary completion: 2025-11-15
• Completion: 2026-11-15
• First posted: 2024-09-19
• Last updated: 2024-09-19

Regulatory

• FDA-regulated device study